Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
Authors:
Open Access
- 1 March 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (3) , 680-687
Abstract
Laboratory and epidemiologic evidence suggest that nonsteroidal anti-inflammatory drug (NSAID) use may be inversely related to the risk of breast cancer; however, the mechanism by which NSAIDs may protect against the development of this disease is uncertain. The objective of this observational study was to assess the relationship between current NSAID use and endogenous estradiol levels, an established breast cancer risk factor. To evaluate this aim, we conducted a cross-sectional investigation among 260 postmenopausal women who were not recently exposed to exogenous hormones. Information on current NSAID use (aspirin, cyclooxygenase-2 inhibitors, and other NSAIDs combined) was collected using a questionnaire at the time of blood draw. Estradiol was quantified in serum by radioimmunoassay. General linear models were used to evaluate the association between NSAID use and serum total estradiol. The age-adjusted and body mass index–adjusted geometric mean serum estradiol concentration among NSAID users (n = 124) was significantly lower than nonusers of NSAIDs (n = 136; 17.8 versus 21.3 pmol/L; P = 0.03). Further adjustment for additional potential confounding factors did not substantially alter estimates (17.7 versus 21.2 pmol/L; P = 0.03). To our knowledge, this report is the first to examine the relationship between NSAID use and serum estradiol in postmenopausal women. These cross-sectional findings suggest that NSAID use may be associated with lower circulating estradiol levels, potentially representing one mechanism through which NSAIDs exert protective effects on breast cancer. (Cancer Epidemiol Biomarkers Prev 2008;17(3):680–7)Keywords
This publication has 42 references indexed in Scilit:
- Aromatase and COX in breast cancer: Enzyme inhibitors and beyondThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup FindingsAmerican Journal of Epidemiology, 2007
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005
- Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor StatusJNCI: Journal of the National Cancer Institute, 2005
- Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancerObstetrics & Gynecology, 2003
- Frequency of use of acetaminophen, nonsteroidal anti‐inflammatory drugs, and aspirin in US womenPharmacoepidemiology and Drug Safety, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ miceInternational Journal of Cancer, 1997
- Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) geneEndocrinology, 1996
- Ovarian angiotensin-converting enzyme activity in humans: relationship to estradiol, age, and uterine pathologyThe Journal of Clinical Endocrinology & Metabolism, 1996